Braden Michael Leonard

10% owner

Braden Michael Leonard (10% owner) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in ADVM. The largest single filing was $2.4M of ADVM (574,886 sh across 3 lots, as filed), executed Dec 1 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$7.5M

shares × price, as filed

Last traded

Apr 23

Filed Apr 27

Median ADV $1.7M across their filed names

Open performance→

Volume by month

Buys $3.3M Sells $10.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Not on file 4 filings

Sector per market data · by filing · past 12 months

Most traded names

ADVM ADVM ADVM · 6 buys · 2 sells 8 filings ANTX

AN2 Therapeutics, Inc. ANTX · 0 buys · 2 sells 2 filings ACRS ACRS ACRS · 0 buys · 1 sell 1 filing ASTC ASTC ASTC · 0 buys · 1 sell 1 filing RPHM RPHM RPHM · 1 buy · 0 sells 1 filing

Recent filings

ACRSSALE Aclaris Therapeutics, Inc. View filing → $1.4M
300,000 sh × $4.53
Exec Apr 23
Filed Apr 27 · 5:30 PM ET ADVMSALE Adverum Biotechnologies, Inc. View filing → $2.2M
524,560 sh × $4.19
Exec Dec 4 2025
Filed Dec 5 2025 · 5:30 PM ET ADVMSALE Adverum Biotechnologies, Inc. View filing → $2.4M
574,886 sh across 3 lots
Exec Dec 1 2025
Filed Dec 3 2025 · 5:30 PM ET ASTCSALE ASTROTECH Corp View filing → $1.6M
220,410 sh × $7.13
Exec Oct 3 2025
Filed Oct 7 2025 · 5:30 PM ET ANTXSALE AN2 Therapeutics, Inc. View filing → $2.9M
2,525,000 sh across 3 lots
Exec May 28 2025
Filed May 30 2025 · 5:30 PM ET ANTXSALE AN2 Therapeutics, Inc. View filing → $218K
200,000 sh × $1.09
Exec May 28 2025
Filed Jun 16 2025 · 5:30 PM ET † ADVMPURCHASE Adverum Biotechnologies, Inc. View filing → $1.0M
350,000 sh across 2 lots
Exec Apr 22 2025
Filed Apr 24 2025 · 5:30 PM ET ADVMPURCHASE Adverum Biotechnologies, Inc. View filing → $103K
20,407 sh × $5.04
Exec Mar 26 2025
Filed Apr 28 2025 · 5:30 PM ET † More filings →